Buscar
Mostrando ítems 1-10 de 58
Nova abordagem terapéutica para dislpidemias: PCSK9
(Universidade Federal de Minas GeraisUFMG, 2015-07-13)
Cardiovascular diseases (CVD) are among many other diseases that strongly put to death people all over the world. In developing countries, including Brazil, the mortality caused by cardiovascular complication has shown ...
PCSK9 conjugated liposomes for targeted delivery of paclitaxel to the cancer cell: a proof-of-concept study
(ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 2022)
Ligand-based targeting of the receptors that are overexpressed explicitly on cancer cells represents an effective drug delivery approach to enhance the chemotherapeutic efficacy. Proprotein convertase subtilisin/kexin type ...
Monthly Pcsk9 Inhibitors: The Choice For Prolonged Duration Of Effect
(Elsevier Ireland LTDClare, 2016)
Correlação dos níveis plasmáticos de proproteína convertase subtilisina kexina tipo 9 (PCSK9) com parâmetros do perfil lipídico e do estresse oxidativo em mulheres jovens e na pós-menopausa
(Universidade Federal de Minas GeraisUFMG, 2018-06-05)
The hormone use, combined oral contraceptives (COC) and postmenopausal hormone therapy (MHT), as well as aging have a direct effect on lipid metabolism and may trigger cardiovascular changes. Pro-protein convertase subtilisin ...
Descripción de la expresión de PCSK9 en pacientes del CMLALM con alta sospecha de hipercolesterolemia familiar
(Universidad Autónoma del Estado de México, 2021)
PCSK9 conjugated liposomes for targeted delivery of paclitaxel to the cancer cell : A proof-of-concept study
(2022-09)
Ligand-based targeting of the receptors that are overexpressed explicitly on cancer cells represents an effective drug delivery approach to enhance the chemotherapeutic efficacy. Proprotein convertase subtilisin/kexin type ...